Masimo Co. (NASDAQ:MASI) Shares Bought by Simplify Asset Management Inc.

Simplify Asset Management Inc. boosted its position in shares of Masimo Co. (NASDAQ:MASI - Free Report) by 120.4% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,670 shares of the medical equipment provider's stock after acquiring an additional 11,838 shares during the period. Simplify Asset Management Inc.'s holdings in Masimo were worth $2,729,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Fifth Third Bancorp raised its holdings in shares of Masimo by 16.4% in the second quarter. Fifth Third Bancorp now owns 695 shares of the medical equipment provider's stock worth $88,000 after buying an additional 98 shares during the last quarter. Oak Thistle LLC raised its holdings in shares of Masimo by 5.2% in the second quarter. Oak Thistle LLC now owns 2,079 shares of the medical equipment provider's stock worth $262,000 after buying an additional 103 shares during the last quarter. GAMMA Investing LLC raised its holdings in shares of Masimo by 75.0% in the second quarter. GAMMA Investing LLC now owns 259 shares of the medical equipment provider's stock worth $33,000 after buying an additional 111 shares during the last quarter. HHM Wealth Advisors LLC raised its holdings in shares of Masimo by 25.0% in the second quarter. HHM Wealth Advisors LLC now owns 625 shares of the medical equipment provider's stock worth $79,000 after buying an additional 125 shares during the last quarter. Finally, Parallel Advisors LLC raised its holdings in shares of Masimo by 48.3% in the fourth quarter. Parallel Advisors LLC now owns 445 shares of the medical equipment provider's stock worth $52,000 after buying an additional 145 shares during the last quarter. Hedge funds and other institutional investors own 85.96% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on MASI. Needham & Company LLC reaffirmed a "hold" rating on shares of Masimo in a report on Friday. Piper Sandler increased their price objective on shares of Masimo from $160.00 to $165.00 and gave the stock an "overweight" rating in a research note on Wednesday, August 7th. Four research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, Masimo has an average rating of "Moderate Buy" and a consensus target price of $144.67.

Masimo Stock Performance

Shares of NASDAQ:MASI traded up $9.69 during midday trading on Friday, reaching $121.42. The company's stock had a trading volume of 2,572,609 shares, compared to its average volume of 655,082. The firm has a market capitalization of $6.46 billion, a PE ratio of 82.60 and a beta of 0.98. Masimo Co. has a twelve month low of $75.22 and a twelve month high of $153.93. The stock has a fifty day moving average of $114.82 and a 200 day moving average of $125.08. The company has a quick ratio of 1.15, a current ratio of 2.09 and a debt-to-equity ratio of 0.55.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The medical equipment provider reported $0.86 EPS for the quarter, beating the consensus estimate of $0.77 by $0.09. The company had revenue of $496.30 million for the quarter, compared to analyst estimates of $493.92 million. Masimo had a net margin of 3.94% and a return on equity of 14.07%. The firm's revenue was up 9.0% on a year-over-year basis. During the same quarter last year, the business earned $0.62 earnings per share. On average, equities analysts expect that Masimo Co. will post 3.87 EPS for the current fiscal year.

Masimo Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.